Prenatal Assessment of Genomes and Exomes (PAGE) (360G-Wellcome-101177_Z_13_A)
Women have ultrasound scans of their baby in pregnancy to check for structural abnormalities (such as a heart defect). If a problem is found, women are offered prenatal testing to check for chromosomal abnormalities in the baby, such as Down’s syndrome. This helps to predict the outcome for the child.The chromosomes in our cells consist of strands of DNA which encode all the genes. Standard genetic testing detects large chromosomal changes that can be seen down a microscope. In some centres additional testing can detect smaller chromosomal changes. Dr Matthew Hurles at the Wellcome Trust Sanger Institute and colleagues plan to look in the greatest possible detail, down to the level of individual building blocks of DNA, to examine the genes. In this study, as the amount of information generated by this testing is vast and the interpretation time-consuming, results cannot be given during the pregnancy. If a genetic reason for the abnormal scan findings is found, this information would be given to parents after pregnancy. This could provide important information about the health of the child or implications for future pregnancies. This research will allow the team to discover new genes responsible for causing abnormalities and, if appropriate, to develop methods for speedy feedback of important information during pregnancy in the future.
Where is this data from?
This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.
Grant Details
Amount Awarded | 1861405 |
Applicant Surname | Hurles |
Approval Committee | Health Innovation Challenge Fund |
Award Date | 2013-04-25T00:00:00+00:00 |
Financial Year | 2012/13 |
Grant Programme: Title | Health Innovation Challenge Fund Award |
Internal ID | 101177/Z/13/A |
Lead Applicant | Prof Matthew Hurles |
Other Applicant(s) | Dr Nicholas Lench, Ms Jane Fisher, Prof Eamonn Maher, Prof Mark Kilby, Prof Michael Parker |
Partnership Name | Health Innovation Challenge Fund |
Partnership Value | 3527905 |
Planned Dates: End Date | 2017-09-30T00:00:00+00:00 |
Planned Dates: Start Date | 2014-10-01T00:00:00+00:00 |
Recipient Org: Country | United Kingdom |
Region | East of England |